Larimar Therapeutics, Inc. (LRMR) short interest & options flow
NASDAQLRMR heads into its Q1 2026 earnings today having shed more than a quarter of its value in a month — and short sellers have been adding to their positions throughout the slide. Bears have been busy. Short interest climbed 17% over the past week alone, reaching nearly 10% of the free float. That's a meaningful positioning shift into a clinical-stage biotech reporting results the…
LRMR cost to borrow surges to 1.11% from 0.29% in one week — a 357% spike driven by tightening short availability.
- Market cap
- $280M
- Next earnings
- 19 Mar 2027
Key data as of 11 Nov 2026
Latest signals on LRMR
- Cost to Borrow
LRMR cost to borrow surges to 1.11% from 0.29% in one week — a 357% spike driven by tightening short availability.
LRMR news and analysis
RSSNo long-form analysis yet for LRMR. Pulse alerts and the live data picture are available on ORTEX.
Open LRMR on ORTEX →Want the live picture for LRMR?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LRMR — free to start on ORTEX.
Sign up for free →Open LRMR on ORTEX